萨库比特里尔/瓦尔萨坦对运动能力的影响:在升位期间开始的预后改善
Massimo Mapelli1,2, Irene Mattavelli3, Stefania Paolillo4
1Centro Cardiologico Monzino, IRCCS, Milan, Italy. massimo.mapelli@ccfm.it.
European journal of clinical pharmacology
|June 27, 2023
概括
萨库比特里尔/瓦尔沙坦显著改善了心力衰竭患者的运动能力,心脏功能和生活质量. 这种治疗也显示出预后益处,表明一种整体的方法来管理心力衰竭与减少喷射率 (HFrEF).
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 运动生理学 运动生理学
背景情况:
- 萨库比特里尔/瓦尔沙坦是心力衰竭的关键治疗方法,心力衰竭的减少喷射率 (HFrEF).
- 之前对其对运动表现的影响的研究表明,结果各不相同.
- 了解剂量依赖性影响对于优化HFrEF管理至关重要.
研究的目的:
- 为了评估sacubitril/valsartan对HFrEF患者运动参数的影响.
- 评估不同剂量萨库比特里尔/瓦尔萨坦的心声和生物标志物变化.
- 确定药物对功能能力和生活质量的影响.
主要方法:
- 预期招募HFrEF门诊患者开始使用sacubitril/valsartan.
- 定期进行评估,包括心肺运动测试 (CPET),心声学和血液采样.
- 逐渐定位sacubitril/valsartan的剂量,从每天两次24/26 mg到每天两次 97/103 mg或最大耐受剂量,并在6个月后进行随访.
主要成果:
- 在峰值氧气摄入量显著改善,并且减少了小时通风/二氧化碳生产斜率.
- 左心室喷射分数 (EF) 从31%增加到37%,NT-proBNP水平显著下降.
- 增强了NYHA功能类,改善了堪萨斯城心肌病问卷-12 (KCCQ-12) 评分,以及更好的代谢运动心脏脏指数 (MECKI).
结论:
- 萨库比特里尔/瓦尔沙坦在心力衰竭管理方面表现出渐进的,整体的改善.
- 治疗对功能能力,心脏结构和生物标志物产生了积极影响.
- 观察到的改善表明,sacubitril/valsartan在HFrEF患者的预后效果有利.
更多相关视频
02:47Author Spotlight: Exercise Test for Evaluation of the Functional Efficacy of the Pig Cardiovascular System
Published on: May 12, 2023
1.4K
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
10.5K
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
467
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
467
01:30Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15
01:20Exercise and Cardiovascular Response
870
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
870
01:22Heart Failure Drugs: β-Blockers
371
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
371
01:25Aortic Regurgitation III: Medical Management
26
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
01:17Exercise and Cardiac Output
1.1K
Regular physical activity is essential for maintaining cardiovascular health, with aerobic exercises being particularly effective. According to the American Heart Association, 150 minutes of moderate to intense aerobic exercise per week is recommended for a healthy heart. Aerobic activities may include brisk walking, running, bicycling, cross-country skiing, and swimming, ideally performed three to five times per week.
Sustained exercise increases the muscles' oxygen demand, which can be...
Sustained exercise increases the muscles' oxygen demand, which can be...
1.1K